Aspen Aerogels, Inc. (NYSE:ASPN) Receives Average Rating of “Moderate Buy” from Analysts

Aspen Aerogels, Inc. (NYSE:ASPNGet Free Report) has been given an average rating of “Moderate Buy” by the ten analysts that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating and nine have issued a buy rating on the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $19.11.

Several research analysts have recently commented on ASPN shares. Craig Hallum dropped their price target on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating on the stock in a research note on Friday, February 14th. Barclays dropped their price target on shares of Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 19th. Seaport Res Ptn lowered shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 12th. TD Cowen started coverage on shares of Aspen Aerogels in a report on Friday. They set a “buy” rating and a $11.00 price objective for the company. Finally, StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a report on Wednesday, February 19th.

Read Our Latest Stock Analysis on Aspen Aerogels

Institutional Trading of Aspen Aerogels

Hedge funds have recently bought and sold shares of the stock. Quest Partners LLC boosted its holdings in Aspen Aerogels by 263.3% in the 3rd quarter. Quest Partners LLC now owns 7,397 shares of the construction company’s stock valued at $205,000 after purchasing an additional 5,361 shares during the period. Sandia Investment Management LP bought a new stake in Aspen Aerogels in the 4th quarter valued at $89,000. Mesirow Financial Investment Management Inc. bought a new stake in Aspen Aerogels in the 3rd quarter valued at $252,000. Kovitz Investment Group Partners LLC bought a new stake in Aspen Aerogels in the 3rd quarter valued at $263,000. Finally, Morse Asset Management Inc bought a new stake in Aspen Aerogels in the 3rd quarter valued at $264,000. 97.64% of the stock is owned by institutional investors.

Aspen Aerogels Stock Down 3.7 %

Aspen Aerogels stock opened at $7.66 on Tuesday. The firm has a market cap of $628.16 million, a PE ratio of 47.85 and a beta of 2.28. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The firm’s 50 day moving average price is $10.61 and its two-hundred day moving average price is $16.60. Aspen Aerogels has a twelve month low of $6.70 and a twelve month high of $33.15.

Aspen Aerogels (NYSE:ASPNGet Free Report) last released its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. On average, research analysts predict that Aspen Aerogels will post 0.17 EPS for the current fiscal year.

About Aspen Aerogels

(Get Free Report

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Recommended Stories

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.